🔎 ADPKD is more than kidney cysts — it’s a systemic disease needing holistic care. With partners at MedUni Innsbruck, Delta4 builds on diagnostic insights to drive new therapies that slow cyst growth and address the wider health burden of #ADPKD patients. #KidneyHealth

Swapped our loft office for a Josefstadt seminar hotel 🔥 Full day of brainstorming, tackling challenges, and fueling Delta4’s next chapter together. #TeamDelta4 #InnovationInAction

In our webinar with CLS, we showed how Hyper-C models reactive astrocytes, revealing neurotoxic mechanisms and drug repositioning opportunities for neuroprotection. Watch: youtu.be/19LP5EwSdb4

Just a few days to go!📣

Delta4 will be at BIO-Europe 2025 in Vienna, Nov 3–5.
Meet our CSO, Dr. Klaus Kratochwill, and discover how our Hyper-C platform can help unlock new therapeutic opportunities.

📩 DM us to schedule a meeting at the conference!

Delta4 hosted a Bioinformatics & -statistics Workshop in Vienna, bringing together PhD students to elevate their CKD research. Learn more: delta4.ai/personalized...

#Delta4 #PICKEDProject

🧬 At Delta4, we turn omics data into actionable insights. By integrating multi-omics layers into our Hyper-C platform, we simulate disease mechanisms, predict drug responses, and uncover new indications — advancing precision drug repositioning for complex and rare diseases.
#AIinBiotech